Nanhua Net Debt from 2010 to 2024

000504 Stock   10.27  0.02  0.20%   
Nanhua Bio's Net Debt is decreasing over the years with slightly volatile fluctuation. Net Debt is expected to dwindle to about 8.8 M. Net Debt is the total debt of Nanhua Bio Medicine minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals
 
Net Debt  
First Reported
2010-12-31
Previous Quarter
9.9 M
Current Value
8.8 M
Quarterly Volatility
616 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Nanhua Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nanhua Bio's main balance sheet or income statement drivers, such as Interest Expense of 10.7 M, Selling General Administrative of 43 M or Total Revenue of 117.7 M, as well as many indicators such as . Nanhua financial statements analysis is a perfect complement when working with Nanhua Bio Valuation or Volatility modules.
  
This module can also supplement various Nanhua Bio Technical models . Check out the analysis of Nanhua Bio Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Nanhua Stock

Nanhua Bio financial ratios help investors to determine whether Nanhua Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nanhua with respect to the benefits of owning Nanhua Bio security.